Home
About Us
Overview
Leadership
Board of Directors
Message from BIO
Programs
Overview
Tamibarotene
SY-2101
SY-5609
Expanded Access Policy
Publications
All Publications
Tamibarotene
SY-2101
SY-5609
Patients
Investors & Media
Partners
Careers
Contact
Investors & Media
Investors & Media
Overview
News
Email Alerts
Press Releases
Events & Presentations
IR Calendar
Presentations
Company Info
Profile
Leadership
Contacts
Analyst Coverage
FAQ
Financial Info
Balance Sheet
Income Statement
Cash Flow
Financial Results
Annual Reports
IRS Tax Form 8937
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Filings
Quarterly Reports
Proxy
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Investor & Media Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All SEC Filings
SEC Filings
Overview
All SEC Filings
Annual Filings
Quarterly Reports
Proxy
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEL AM
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-4MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Date
Form
Description
PDF
XBRL
Pages
08/09/22
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-31.1
EX-31.2
EX-32.1
EX-32.2
63
08/09/22
424B3
Prospectus filed pursuant to Rule 424(b)(3)
713
08/08/22
EFFECT
Notice of Effectiveness
1
08/04/22
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
08/01/22
S-4/A
Registration of securities issued in business combination transactions
Documents
EX-5.1
EX-99.1
EX-99.2
16
07/20/22
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
1
07/18/22
DEL AM
Separately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statement
1
07/18/22
S-4
Registration of securities issued in business combination transactions
Documents
EX-10.5
EX-23.1
EX-23.2
EX-99.3
EX-99.4
EX-FILING FEES
746
07/13/22
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
8
07/13/22
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Documents
EX-99.1
EX-99.2
95
12
13
14
15
16
17
18
19
20
21